The Recombinant Human TRPV6 Channel Functions As Ca2+ Sensor in Human Embryonic Kidney and Rat Basophilic Leukemia Cells
Overview
Affiliations
The activation mechanism of the recently cloned human transient receptor potential vanilloid type 6 (TRPV6) channel, originally termed Ca(2+) transporter-like protein and Ca(2+) transporter type 1, was investigated in whole-cell patch-clamp experiments using transiently transfected human embryonic kidney and rat basophilic leukemia cells. The TRPV6-mediated currents are highly Ca(2+)-selective, show a strong inward rectification, and reverse at positive potentials, which is similar to store-operated Ca(2+) entry in electrically nonexcitable cells. The gating of TRPV6 channels is strongly dependent on the cytosolic free Ca(2+) concentration; lowering the intracellular free Ca(2+) concentration results in Ca(2+) influx, and current amplitude correlates with the intracellular EGTA or BAPTA concentration. This is also the case for TRPV6-mediated currents in the absence of extracellular divalent cations; compared with endogenous currents in nontransfected rat basophilic leukemia cells, these TRPV6-mediated monovalent currents reveal differences in reversal potential, inward rectification, and slope at very negative potentials. Release of stored Ca(2+) by inositol 1,4,5-trisphosphate and/or the sarco/endoplasmic reticulum Ca(2+)-ATPase inhibitor thapsigargin appears not to be involved in TRPV6 channel gating in both cell lines but, in rat basophilic leukemia cells, readily activates the endogenous Ca(2+) release-activated Ca(2+) current. In conclusion, TRPV6, expressed in human embryonic kidney cells and in rat basophilic leukemia cells, functions as a Ca(2+)-sensing Ca(2+) channel independently of procedures known to deplete Ca(2+) stores.
Structural mechanism of human oncochannel TRPV6 inhibition by the natural phytoestrogen genistein.
Neuberger A, Trofimov Y, Yelshanskaya M, Nadezhdin K, Krylov N, Efremov R Nat Commun. 2023; 14(1):2659.
PMID: 37160865 PMC: 10169861. DOI: 10.1038/s41467-023-38352-5.
Advances in Intracellular Calcium Signaling Reveal Untapped Targets for Cancer Therapy.
Sharma A, Ramena G, Elble R Biomedicines. 2021; 9(9).
PMID: 34572262 PMC: 8466575. DOI: 10.3390/biomedicines9091077.
Baio G, Fabbi M, Cilli M, Rosa F, Boccardo S, Valdora F PLoS One. 2020; 15(9):e0224414.
PMID: 32931488 PMC: 7491733. DOI: 10.1371/journal.pone.0224414.
Arbabian A, Iftinca M, Altier C, Singh P, Isambert H, Coscoy S Channels (Austin). 2020; 14(1):101-109.
PMID: 32186440 PMC: 7153789. DOI: 10.1080/19336950.2020.1740506.
TRPV6 as A Target for Cancer Therapy.
Stewart J J Cancer. 2020; 11(2):374-387.
PMID: 31897233 PMC: 6930427. DOI: 10.7150/jca.31640.